| Date |
Report No. |
Title |
| Date Nov. 15, 2005 |
Report No. GAO-06-200 |
Title
United States Government Accountability Office GAO
November 2005 Report to Congressional Committees DRUG CONTROL Agencies Need to Plan for Likely Declines in Drug Interdiction Assets, and Develop Better Performance Measures for Transit Zone Operations GAO-06-200 a November 2005 DRUG CONTROL Highlights
Highlights of GAO-06-200, a report to congressional committees Accountability Integrity Reliabili... |
| Date Nov. 14, 2005 |
Report No. GAO-06-109 |
Title
United States Government Accountability Office GAO
November 2005 Report to Congressional Requesters FOOD AND DRUG ADMINISTRATION Decision Process to Deny Initial Application for Over-the-Counter Marketing of the Emergency Contraceptive Drug Plan B Was Unusual GAO-06-109 November 2005 FOOD AND DRUG ADMINISTRATION Highlights
Highlights of GAO-06-109, a report to congressional requesters Accountabili... |
| Date Nov. 3, 2005 |
Report No. GAO-06-243R |
Title
United States Government Accountability Office Washington, DC 20548 November 3, 2005 The Honorable Tom Davis Chairman The Honorable Henry Waxman Ranking Minority Member Committee on Government Reform House of Representatives Subject: Anabolic Steroids Are Easily Purchased Without a Prescription and Present Significant Challenges to Law Enforcement Officials This report responds to your request tha... |
| Date Oct. 31, 2005 |
Report No. GAO-06-78R |
Title
United States Government Accountability Office Washington, DC 20548 October 28, 2005 The Honorable Henry A. Waxman Ranking Minority Member Committee on Government Reform House of Representatives Subject: Medicare: CMS’s Implementation and Oversight of the Medicare Prescription Drug Discount Card and Transitional Assistance Program Dear Mr. Waxman: The Medicare Prescription Drug, Improvement and ... |
| Date Oct. 31, 2005 |
Report No. GAO-06-17R |
Title
United States Government Accountability Office Washington, DC 20548 October 31, 2005 The Honorable Charles E. Grassley Chairman The Honorable Max Baucus Ranking Minority Member Committee on Finance United States Senate The Honorable Joe Barton Chairman The Honorable John D. Dingell Ranking Minority Member Committee on Energy and Commerce House of Representatives The Honorable William M. Thomas Cha... |
| Date Oct. 31, 2005 |
Report No. GAO-06-69R |
Title
United States Government Accountability Office Washington, DC 20548 October 31, 2005 The Honorable Edward Whitfield Chairman Subcommittee on Oversight and Investigations Committee on Energy and Commerce House of Representatives Subject: Medicaid: States’ Payments for Outpatient Prescription Drugs Dear Mr. Chairman: Spending on outpatient prescription drug coverage for Medicaid beneficiaries has ... |
| Date Sept. 26, 2005 |
Report No. GAO-05-238 |
Title
United States Government Accountability Office GAO
September 2005 Report to Congressional Requesters DRUG OFFENDERS Various Factors May Limit the Impacts of Federal Laws That Provide for Denial of Selected Benefits GAO-05-238 September 2005 DRUG OFFENDERS Highlights
Highlights of GAO-05-238, a report to congressional requesters Accountability Integrity Reliability Various Factors May Limit the Imp... |
| Date Sept. 8, 2005 |
Report No. GAO-05-372 |
Title
United States Government Accountability Office GAO
September 2005 Report to Congressional Requesters PRESCRIPTION DRUGS Strategic Framework Would Promote Accountability and Enhance Efforts to Enforce the Prohibitions on Personal Importation GAO-05-372 September 2005 PRESCRIPTION DRUGS Highlights
Highlights of GAO-05-372, a report to congressional requesters Accountability Integrity Reliability Str... |
| Date Aug. 15, 2005 |
Report No. GAO-05-779 |
Title
United States Government Accountability Office GAO
August 2005 Report to Congressional Requesters PRESCRIPTION DRUGS Price Trends for Frequently Used Brand and Generic Drugs from 2000 through 2004 GAO-05-779 August 2005 PRESCRIPTION DRUGS Highlights
Highlights of GAO-05-779, a report to congressional requesters Accountability Integrity Reliability Price Trends for Frequently Used Brand and Generic... |
| Date July 14, 2005 |
Report No. GAO-05-733R |
Title
United States Government Accountability Office Washington, DC 20548 July 14, 2005 The Honorable Michael O. Leavitt The Secretary of Health and Human Services Subject: Medicare: Radiopharmaceutical Purchase Prices for CMS Consideration in Hospital Outpatient Rate-Setting
Dear Mr. Secretary: In our recent report on hospital outpatient drug purchase prices, Medicare: Drug Purchase Prices for CMS Cons... |
| Date June 30, 2005 |
Report No. GAO-05-581R |
Title
United States Government Accountability Office Washington, DC 20548 June 30, 2005 The Honorable Michael O. Leavitt The Secretary of Health and Human Services Subject: Medicare: Drug Purchase Prices for CMS Consideration in Hospital Outpatient Rate-Setting Dear Mr. Secretary: Medicare pays hospitals for drugs that beneficiaries receive as part of their treatment in hospital outpatient departments. ... |
| Date June 22, 2005 |
Report No. GAO-05-555 |
Title
United States Government Accountability Office GAO
June 2005 Report to the Chairman, Subcommittee on Oversight and Investigations, Committee on Veterans’ Affairs, House of Representatives MAIL ORDER PHARMACIES DOD’s Use of VA’s Mail Pharmacy Could Produce Savings and Other Benefits GAO-05-555 June 2005 MAIL ORDER PHARMACIES Highlights
Highlights of GAO-05-555, a report to the Chairman, Subco... |
| Date June 22, 2005 |
Report No. GAO-05-850T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 2:00 p.m. EDT Wednesday, June 22, 2005 Testimony Before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives MEDICAID DRUG REBATE PROGRAM Inadequate Oversight Raises Concerns about Rebates Paid to States
Statement of Kathleen King Director, Health Care GAO-05-850T June 22, 2005 ... |
| Date May 17, 2005 |
Report No. GAO-05-653T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 9:30 a.m. EDT Tuesday, May 17, 2005 Testimony Before the Chairman, Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives DRUG TESTS Products to Defraud Drug Use Screening Tests Are Widely Available
Statement of Robert J. Cramer, Managing Director Office of Speci... |
| Date March 31, 2005 |
Report No. GAO-05-175 |
Title
United States Government Accountability Office GAO
March 2005 Report to the Subcommittee on Transportation, Treasury, the Judiciary, Housing and Urban Development, and Related Agencies, Committee on Appropriations, U.S. Senate ANTI-DRUG MEDIA CAMPAIGN An Array of Services Was Provided, but Most Funds Were Committed to Buying Media Time and Space GAO-05-175 March 2005 ANTI-DRUG MEDIA CAMPAIGN Highl... |
| Date Feb. 28, 2005 |
Report No. GAO-05-219 |
Title
United States Government Accountability Office GAO
February 2005 Report to Congressional Committees ADULT DRUG COURTS Evidence Indicates Recidivism Reductions and Mixed Results for Other Outcomes GAO-05-219 February 2005 ADULT DRUG COURTS Highlights
Highlights of GAO-05-219, a report to congressional committees Accountability Integrity Reliability Evidence Indicates Recidivism Reductions and Mixed... |
| Date Feb. 14, 2005 |
Report No. GAO-05-205 |
Title
United States Government Accountability Office GAO
February 2005 Report to Congressional Committees RETIREE HEALTH BENEFITS Options for Employment-Based Prescription Drug Benefits under the Medicare Modernization Act GAO-05-205 February 2005 RETIREE HEALTH BENEFITS Highlights
Highlights of GAO-05-205, a report to congressional committees Accountability Integrity Reliability Options for Employment-... |
| Date Feb. 4, 2005 |
Report No. GAO-05-102 |
Title
United States Government Accountability Office GAO
February 2005 Report to Congressional Requesters MEDICAID DRUG REBATE PROGRAM Inadequate Oversight Raises Concerns about Rebates Paid to States GAO-05-102 February 2005 MEDICAID DRUG REBATE PROGRAM Highlights
Highlights of GAO-05-102, a report to congressional requesters Accountability Integrity Reliability Inadequate Oversight Raises Concerns abo... |
| Date Jan. 11, 2005 |
Report No. GAO-05-133 |
Title
United States Government Accountability Office GAO
January 2005 Report to Congressional Requesters GLOBAL HIV/AIDS EPIDEMIC Selection of Antiretroviral Medications Provided under U.S. Emergency Plan Is Limited GAO-05-133 January 2005 GLOBAL HIV/AIDS EPIDEMIC Highlights
Highlights of GAO-05-133, a report to congressional requesters Accountability Integrity Reliability Selection of Antiretroviral Me... |
| Date Dec. 1, 2004 |
Report No. GAO-05-142R |
Title
United States Government Accountability Office Washington, DC 20548 December 1, 2004 The Honorable Joe Barton Chairman Committee on Energy and Commerce House of Representatives Subject: Medicare Chemotherapy Payments: New Drug and Administration Fees Are Closer to Providers’ Costs Dear Mr. Chairman: The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 1 (MMA) required the S... |
| Date Oct. 12, 2004 |
Report No. GAO-05-72 |
Title
United States Government Accountability Office GAO
October 2004 Report to Congressional Committees MEDICARE Appropriate Dispensing Fee Needed for Suppliers of Inhalation Therapy Drugs GAO-05-72 a October 2004 MEDICARE Highlights
Highlights of GAO-05-72, a report to congressional committees Accountability Integrity Reliability Appropriate Dispensing Fee Needed for Suppliers of Inhalation Therapy Dr... |
| Date Oct. 6, 2004 |
Report No. GAO-05-104R |
Title
United States Government Accountability Office Washington, DC 20548 October 6, 2004 The Honorable Olympia J. Snowe Chair Committee on Small Business and Entrepreneurship United States Senate The Honorable Ron Wyden Ranking Minority Member Subcommittee on Consumer Affairs and Product Safety Committee on Commerce, Science, and Transportation United States Senate Subject: Prescription Drugs: Trends i... |
| Date Sept. 17, 2004 |
Report No. GAO-04-772 |
Title
United States Government Accountability Office GAO
September 2004 Report to the Chairman, Subcommittee on Health, Committee on Ways and Means, House of Representatives MEDICARE Information Needed to Assess Adequacy of Rate-Setting Methodology for Payments for Hospital Outpatient Services GAO-04-772 a September 2004 MEDICARE Information Needed to Assess Adequacy of Rate-Setting Methodology for Paym... |
| Date Aug. 31, 2004 |
Report No. GAO-04-1036 |
Title
United States Government Accountability Office GAO
August 2004 Report to the Chairman, Subcommittee on Commerce, Justice, State, and the Judiciary, and Related Agencies, Committee on Appropriations, House of Representatives FBI TRANSFORMATION Data Inconclusive on Effects of Shift to CounterterrorismRelated Priorities on Traditional Crime Enforcement GAO-04-1036 August 2004 FBI TRANSFORMATION Data ... |
| Date July 22, 2004 |
Report No. GAO-04-839T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 9:00 a.m. EDT Thursday, July 22, 2004 Testimony Before the Permanent Subcommittee on Investigations, Committee on Governmental Affairs, U.S. Senate PRESCRIPTION DRUGS Preliminary Observations on Efforts to Enforce the Prohibitions on Personal Importation
Statement of Richard M. Stana, Director Homeland Security ... |
| Date July 21, 2004 |
Report No. GAO-04-755 |
Title
United States Government Accountability Office GAO
July 2004 Report to the Chairman, Subcommittee on Oversight and Investigations, Committee on Veterans’ Affairs, House of Representatives VA MEDICAL CENTERS Internal Control over Selected Operating Functions Needs Improvement GAO-04-755 a July 2004 VA MEDICAL CENTERS Internal Control over Selected Operating Functions Needs Improvement Highlights ... |
| Date July 12, 2004 |
Report No. GAO-04-784 |
Title
United States General Accounting Office GAO
July 2004 Report to the Chairman, Subcommittee on Foreign Operations, Export Financing, and Related Programs, Committee on Appropriations, House of Representatives GLOBAL HEALTH U.S. AIDS Coordinator Addressing Some Key Challenges to Expanding Treatment, but Others Remain GAO-04-784 a July 2004 GLOBAL HEALTH U.S. AIDS Coordinator Addressing Some Key Chal... |
| Date July 6, 2004 |
Report No. GAO-04-946T |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 4:00 p.m. EDT Tuesday, July 6, 2004 Testimony
Before the Subcommittee on Crime, Terrorism, and Homeland Security, Committee on the Judiciary, House of Representatives DRUG REHABILITATION CLINICS Illegal Drug Activities Near Some District of Columbia Clinics Undermine Clinic Services and Patient Rehabilitation
Statement... |
| Date July 2, 2004 |
Report No. GAO-04-726 |
Title
United States General Accounting Office GAO
July 2004 Report to the Honorable Charles E. Grassley, Chairman, Caucus on International Narcotics Control, U.S. Senate DRUG CONTROL U.S. Nonmilitary Assistance to Colombia Is Beginning to Show Intended Results, but Programs Are Not Readily Sustainable GAO-04-726 a July 2004 DRUG CONTROL U.S. Nonmilitary Assistance to Colombia Is Beginning to Show Intend... |
| Date June 30, 2004 |
Report No. GAO-04-480 |
Title
United States General Accounting Office GAO
June 2004 Report to the Committee on Finance, U.S. Senate MEDICAID WAIVERS HHS Approvals of Pharmacy Plus Demonstrations Continue to Raise Cost and Oversight Concerns GAO-04-480 June 2004 MEDICAID WAIVERS HHS Approvals of Pharmacy Plus Demonstrations Continue to Raise Cost and Oversight Concerns Highlights of GAO-04-480, a report to the Committee on Fina... |
| Date June 22, 2004 |
Report No. GAO-04-718 |
Title
United States General Accounting Office GAO
June 2004 Report to the Committee on Government Reform, House of Representatives CONTRACT MANAGEMENT Further Efforts Needed to Sustain VA’s Progress in Purchasing Medical Products and Services GAO-04-718 a June 2004 CONTRACT MANAGEMENT Further Efforts Needed to Sustain VA’s Progress in Purchasing Medical Products and Services Highlights of GAO-04-718... |
| Date June 17, 2004 |
Report No. GAO-04-820 |
Title
United States General Accounting Office GAO
June 2004 Report to the Chairman, Permanent Subcommittee on Investigations, Committee on Governmental Affairs, U.S. Senate INTERNET PHARMACIES Some Pose Safety Risks for Consumers GAO-04-820 a June 2004 INTERNET PHARMACIES Some Pose Safety Risks for Consumers
Highlights of GAO-04-820, a report to the Chairman, Permanent Subcommittee on Investigations, Co... |
| Date June 17, 2004 |
Report No. GAO-04-888T |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 9:00 a.m. EDT Thursday, June 17, 2004 Testimony Before the Permanent Subcommittee on Investigations, Committee on Governmental Affairs, U.S. Senate INTERNET PHARMACIES Some Pose Safety Risks for Consumers and Are Unreliable in Their Business Practices
Statement of Marcia Crosse Director, Health Care—Public Health and... |
| Date June 4, 2004 |
Report No. GAO-04-728 |
Title
GAO
June 2004 Report to Congressional Requesters AVIATION SECURITY Further Steps Needed to Strengthen the Security of Commercial Airport Perimeters and Access Controls GAO-04-728 June 2004 AVIATION SECURITY Further Steps Needed to Strengthen the Security of Commercial Airport Perimeters and Access Controls Highlights of GAO-04-728, a report to congressional requesters In the 2 years since passage ... |
| Date April 22, 2004 |
Report No. GAO-04-490 |
Title
United States General Accounting Office GAO
April 2004 Report to Congressional Requesters ANTIBIOTIC RESISTANCE Federal Agencies Need to Better Focus Efforts to Address Risk to Humans from Antibiotic Use in Animals GAO-04-490 a April 2004 ANTIBIOTIC RESISTANCE Federal Agencies Need to Better Focus Efforts to Address Risk to Humans from Antibiotic Use in Animals Highlights of GAO-04-490, a report t... |
| Date March 4, 2004 |
Report No. GAO-04-524T |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 1:00 p.m. EST Thursday, March 4, 2004 Testimony Before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives PRESCRIPTION DRUGS State Monitoring Programs May Help to Reduce Illegal Diversion
Statement of Marcia Crosse Director, Health Care—Public Health and Military Health Care Issues... |
| Date Dec. 19, 2003 |
Report No. GAO-04-110 |
Title
United States General Accounting Office GAO
December 2003 Report to Congressional Requesters PRESCRIPTION DRUGS OxyContin Abuse and Diversion and Efforts to Address the Problem GAO-04-110 December 2003 PRESCRIPTION DRUGS OxyContin Abuse and Diversion and Efforts to Address the Problem Highlights of GAO-04-110, a report to congressional requesters Amid heightened awareness that many patients with c... |
| Date Nov. 14, 2003 |
Report No. GAO-04-163 |
Title
United States General Accounting Office GAO
November 2003 Report to Congressional Requesters TERRORIST FINANCING U.S. Agencies Should Systematically Assess Terrorists’ Use of Alternative Financing Mechanisms GAO-04-163 November 2003 TERRORIST FINANCING U.S. Agencies Should Systematically Assess Terrorists' Use of Alternative Financing Mechanisms Highlights of GAO-04-163, a report to congressiona... |
| Date Oct. 24, 2003 |
Report No. GAO-04-105 |
Title
United States General Accounting Office GAO
October 2003 Report to Congressional Requesters FEDERAL DRUG OFFENSES Departures from Sentencing Guidelines and Mandatory Minimum Sentences, Fiscal Years 1999-2001 GAO-04-105 October 2003 FEDERAL DRUG OFFENSES Departures from Sentencing Guidelines and Mandatory Minimum Sentences, Fiscal Years 1999-2001 Highlights of GAO-04-105, a report to congressional ... |
| Date Oct. 23, 2003 |
Report No. GAO-04-195T |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. Thursday, October 23, 2003 Testimony Before the Committee on Health, Education, Labor, and Pensions, U.S. Senate PRESCRIPTION DRUGS State and Federal Oversight of Drug Compounding by Pharmacies
Statement of Janet Heinrich Director, Health Care—Public Health Issues GAO-04-195T October 23, 2003 PRESCRIPTION ... |
| Date Sept. 26, 2003 |
Report No. GAO-03-950 |
Title
United States General Accounting Office GAO
September 2003 Report to Congressional Committees PEDIATRIC DRUG RESEARCH Food and Drug Administration Should More Efficiently Monitor Inclusion of Minority Children GAO-03-950 September 2003 PEDIATRIC DRUG RESEARCH Food and Drug Administration Should More Efficiently Monitor Inclusion of Minority Children Highlights of GAO-03-950, a report to the Commit... |
| Date Sept. 3, 2003 |
Report No. GAO-03-912 |
Title
United States General Accounting Office GAO
September 2003 Report to Congressional Requesters PRESCRIPTION DRUG DISCOUNT CARDS Savings Depend on Pharmacy and Type of Card Used GAO-03-912 September 2003 PRESCRIPTION DRUG DISCOUNT CARDS
Highlights of GAO-03-912, a report to congressional requesters Savings Depend on Pharmacy and Type of Card Used While prescription drugs have become an increasingly ... |
| Date July 23, 2003 |
Report No. GAO-03-1042T |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. Wednesday, July 23, 2003 Testimony Before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives DIETARY SUPPLEMENTS CONTAINING EPHEDRA Health Risks and FDA’s Oversight
Statement of Marcia Crosse Acting Director, Health Care—Public Health and Science ... |
| Date June 16, 2003 |
Report No. GAO-03-783 |
Title
United States General Accounting Office GAO
June 2003 Report to Congressional Committees DRUG CONTROL Specific Performance Measures and Long-Term Costs for U.S. Programs in Colombia Have Not Been Developed GAO-03-783 a June 2003 DRUG CONTROL Specific Performance Measures and Long-Term Costs for U.S. Programs in Colombia Have Not Been Developed Highlights of GAO-03-783, a report to congressional co... |
| Date June 3, 2003 |
Report No. GAO-03-820T |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 9:30 a.m. EDT Tuesday, June 3, 2003 Testimony Before the Caucus on International Narcotics Control, U.S. Senate DRUG CONTROL Financial and Management Challenges Continue to Complicate Efforts to Reduce Illicit Drug Activities in Colombia
Statement of Jess T. Ford, Director International Affairs and Trade GAO-03-820T Ju... |
| Date April 9, 2003 |
Report No. GAO-03-650T |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 11:00 a.m. Wednesday, April 9, 2003 Testimony Before the Committee on Ways and Means, House of Representatives MEDICARE Observations on Program Sustainability and Strategies to Control Spending on Any Proposed Drug Benefit
Statement of David M. Walker Comptroller General of the United States GAO-03-650T April 9, 2003 M... |
| Date March 31, 2003 |
Report No. GAO-03-494 |
Title
United States General Accounting Office GAO
March 2003 Report to the Chairman, Subcommittee on Wellness and Human Rights, Committee on Government Reform, House of Representatives DIETARY SUPPLEMENTS Review of Health-Related Call Records for Users of Metabolife 356 GAO-03-494 a March 2003 DIETARY SUPPLEMENTS
Highlights of GAO-03-494, a report to the Chairman, Subcommittee on Wellness and Human Righ... |
| Date Jan. 15, 2003 |
Report No. GAO-03-172R |
Title
United States General Accounting Office Washington, DC 20548 January 15, 2003 The Honorable Richard J. Durbin United States Senate Subject: Youth Illicit Drug Use Prevention: DARE Long-Term Evaluations and Federal Efforts to Identify Effective Programs Dear Senator Durbin: The use of illicit drugs, particularly marijuana, is a problem among our nation’s youth. The adverse effects of illicit drug... |
| Date Jan. 10, 2003 |
Report No. GAO-03-196 |
Title
United States General Accounting Office GAO
January 2003 Report to the Honorable Byron L. Dorgan, U.S. Senate FEDERAL EMPLOYEES’ HEALTH BENEFITS Effects of Using Pharmacy Benefit Managers on Health Plans, Enrollees, and Pharmacies GAO-03-196 January 2003 FEDERAL EMPLOYEES’ HEALTH BENEFITS
Highlights of GAO-03-196, a report to the Honorable Byron L. Dorgan, U.S. Senate Effects of Using Pharmacy... |
| Date Jan. 10, 2003 |
Report No. GAO-03-184 |
Title
United States General Accounting Office GAO
January 2003 Report to the Ranking Minority Member, Subcommittee on Health, Committee on Ways and Means, House of Representatives MEDICARE Payment for Blood Clotting Factor Exceeds Providers’ Acquisition Cost GAO-03-184 January 2003 MEDICARE Payment for Blood Clotting Factor Exceeds Providers’ Acquisition Cost Highlights of GAO-03-184, a report to Ra... |
